CompoAtlas

PiantoBiotic Ô Féminin

Food supplement declared in France, declaration No 2022-2-786, decision dated 16 February 2022

PiantoBiotic Ô Féminin (Pianto - B.St-Joseph) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
Pianto - B.St-Joseph
Food business operator placing the product on the market
Pianto Healthcare Sàrl
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Flacon
Daily dose
30 ml
Directions for use
Adultes: 30 ml/jr (2 c. à s); Enfants dès 12 ans: 15 ml/jr (1 c. à s.)
Intended populations
Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Cycles féminins

Declaration 231449, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Verbena officinalis L.Parties aériennesExtrait sec aqueux553 mg
Vaccinium myrtillus L.FruitPression à froid397.2 mg
Alchemilla vulgaris L.Parties aériennesExtrait sec hydroalcoolique243 mg
Daucus carota L.RacinePoudre (de plantes séchées ou broyées)156.6 mg
Rubus idaeus L.FruitPression à froid112 mg
Vitex agnus-castus L.FruitExtrait sec aqueux8.8 mg
Ribes nigrum L.FruitPression à froid1.4 g

Other active ingredients

NamePer day
Arabinogalactanesnot declared
Pollennot declared
mielnot declared

Micro-organisms

StrainPer day
Saccharomyces Cerevisiae Saccharomyces cerevisiae141,000,000,000 (unit not declared)

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
L-sélénométhionineSélénium255 µg50 µg
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
RiboflavineVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
Sulfate de zincZinc25 mg15 mg

Additives

E300, E307

Other ingredients

Rosmarinus officinalis L., Thymus vulgaris L., Citrus limon (L.) Burm. f., Lavandula angustifolia Mill., Cupressus sempervirens L., Origanum compactum Benth., Zingiber officinale Roscoe, Juniperus communis L., Abies sibirica Ledeb., Ocimum basilicum L., Artemisia dracunculus L., Laurus nobilis L., Chamaemelum nobile (L.) All., Mentha x piperita L., Carum carvi L., Citrus sinensis (L.) Osbeck, Pimpinella anisum L., Foeniculum vulgare Mill., Citrus paradisi Macfad., Citrus reticulata Blanco, Satureja montana L., fructose

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Il est conseillé de ne pas dépasser la dose journalière recommandée.Les compléments alimentaires ne se substituent pas à une alimentation variée, équilibrée et à un mode de vie sain.Tenir hors de portée des jeunes enfants.Déconseillé chez l'enfant de moins de 6 ans, la femme enceinte ou allaitante et en cas d'allergie aux produits de la ruche.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vaccinium myrtillus L.
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

  • Daucus carota L.
    Read the warning, when it applies and the studies cited

    CARROT - DAUCUS CAROTA SUBSP. SATIVUS

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing more than 6,000 μg of beta-carotene, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are a tobacco smoker (Touvier et al. 2005; Omenn et al. 1996; ATBC 1994).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

  • Vitex agnus-castus L.
    Read the warning, when it applies and the studies cited

    CHASTE TREE - VITEX AGNUS-CASTUS

    Route of administration: Oral (WHO 2009; Bradley 2006; Mills and Bone 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking hormone-containing medications such as progesterone preparations, oral contraceptives or hormone replacement therapy (Brinker 2010; WHO 2009; Bradley 2006).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant, breastfeeding or attempting to conceive unless you have consulted with a health care practitioner/health care provider/health care professional/doctor/physician (EMA 2018; Najib et al. 2022; Brinker 2010; WHO 2009; Dugoua et al. 2008; ESCOP 2003; Blumenthal 2000; Mills and Bone 2000).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 March 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Pianto - B.St-Joseph

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line